These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7336144)

  • 1. Heparin levels and activated clotting time (ACT) during open heart surgery.
    Stenbjerg S; Berg E; Albrechtsen OK
    Scand J Haematol; 1981 Apr; 26(4):281-4. PubMed ID: 7336144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activated coagulation time and the concentration of heparin in assessing the level of blood heparinization during operations using artificial blood circulation].
    Khodas MIa; Piatnitskaia GKh; Savina ME; Smirnova LA
    Anesteziol Reanimatol; 1989; (2):11-5. PubMed ID: 2742179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with activated clotting time (ACT) controlled heparinization in open heart surgery.
    Albrechtsen OK; Stenbjerg S; Berg E
    Thorac Cardiovasc Surg; 1982 Apr; 30(2):109-12. PubMed ID: 6179241
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of two techniques.
    Mabry CD; Thompson BW; Read RC; Campbell GS
    Surgery; 1981 Nov; 90(5):889-95. PubMed ID: 7302842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of ACT as measured with three commercially available devices with circulating heparin level during cardiac surgery.
    Niles SD; Sutton RG; Ploessl J; Pennell B
    J Extra Corpor Technol; 1995 Dec; 27(4):197-200. PubMed ID: 10172651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin monitoring during cardiac surgery. Part 2: Calculating the overestimation of heparin by the activated clotting time.
    Raymond PD; Ray MJ; Callen SN; Marsh NA
    Perfusion; 2003 Sep; 18(5):277-81. PubMed ID: 14604243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of activated coagulation time for controlling the heparinization level during operations with artificial circulation].
    Dement'eva II; Savina ME; Piatnitskaia GKh
    Anesteziol Reanimatol; 1980 Aug; (4):29-32. PubMed ID: 7416544
    [No Abstract]   [Full Text] [Related]  

  • 9. [Haemochron--a simple method of monitoring heparin level during extracorporeal circulation].
    Saggau W; Lüllig H; Storch HH; Tanzeem A; Schmitz W; Hissen W
    Chir Forum Exp Klin Forsch; 1978; (1978):119-22. PubMed ID: 752575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation.
    Koster A; Despotis G; Gruendel M; Fischer T; Praus M; Kuppe H; Levy JH
    Anesth Analg; 2002 Jul; 95(1):26-30, table of contents. PubMed ID: 12088937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.
    Paniccia R; Fedi S; Carbonetto F; Noferi D; Conti P; Bandinelli B; Giusti B; Evangelisti L; Pretelli P; Palmarini MF; Abbate R; Prisco D
    Anesthesiology; 2003 Jul; 99(1):54-9. PubMed ID: 12826842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.
    Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Spitznagel E; Cox JL; Lappas DG
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1076-82. PubMed ID: 7983877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test.
    Wallock M; Jeske WP; Bakhos M; Walenga JM
    Perfusion; 2001 Mar; 16(2):147-53. PubMed ID: 11334198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated clotting time (ACT) monitoring of intraoperative heparinization in peripheral vascular surgery.
    Mabry CD; Thompson BW; Read RC
    Am J Surg; 1979 Dec; 138(6):894-900. PubMed ID: 507308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the activated whole blood clotting time (ACT) in vitro.
    Stenbjerg S; Berg E; Albrechtsen OK
    Scand J Haematol; 1979 Sep; 23(3):239-44. PubMed ID: 504972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
    Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
    Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin monitoring during cardiac surgery. Part 1: Validation of whole-blood heparin concentration and activated clotting time.
    Raymond PD; Ray MJ; Callen SN; Marsh NA
    Perfusion; 2003 Sep; 18(5):269-76. PubMed ID: 14604242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patients.
    Wang JS; Lin CY; Karp RB
    Anesth Analg; 1994 Jul; 79(1):9-13. PubMed ID: 8010461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass.
    Culliford AT; Gitel SN; Starr N; Thomas ST; Baumann FG; Wessler S; Spencer FC
    Ann Surg; 1981 Jan; 193(1):105-11. PubMed ID: 6970015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.